TABLE 4

Effect of l-DOPA treatment on high- and low-affinity striatal α -CtxMII-sensitive and α -CtxMII-resistant 125I-epibatidine binding sites

Binding of 125I-epibatidine (400 pM) was inhibited by a range of α -CtxMII concentrations (0.1-3000 nM) using striatal membranes from control and l-DOPA–treated animals. The densities of high- and low-affinity α -CtxMII-sensitive and α -CtxMII-resistant 125I-epibatidine binding sites were determined in each case and compared between control and l-DOPA–treated animals. Each value is the mean ± S.E.M. of four animals.

Treatment Group α-CtxMII—Sensitive Sites α-CtxMII—Resistant
High Affinity Low Affinity
fmol / mg of protein
Control 9.5 ± 0.6 10.1 ± 1.7 26.2 ± 2.6
l-DOPA 10.5 ± 0.3 4.1 ± 0.7* 25.9 ± 2.1
  • * p < 0.02, significantly different from control animals not receiving l-DOPA.